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RNA interferencea b s t r a c t
Smad7 has a key role in apoptosis of mammalian ovarian granulosa cells (GCs), as it antagonizes and
ﬁne-tunes transforming growth factor b (TGFb) signaling. This study demonstrates that miR-92a
regulates GC apoptosis in pig ovaries by targeting Smad7 directly. The expression level of miR-92a
was down-regulated in atretic porcine follicles, whereas miR-92a expression led to inhibition of
GC apoptosis. The Smad7 gene was identiﬁed as a direct target of miR-92a using a dual-luciferase
reporter assay. Transfection of GCs with miR-92a mimics decreased Smad7 mRNA and protein levels,
whereas expression of an miR-92a inhibitor in GCs had the opposite effect. In addition, knockdown
of Smad7 prevented GC apoptosis in cells that expressed the miR-92a inhibitor.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The transforming growth factor b (TGF-b) signaling pathway
plays a critical role in cell proliferation, differentiation, apoptosis,
and senescence [1,2], and is indispensable for various aspects of
female reproduction [3,4]. Dysregulation of the TGF-b signaling
pathway can result in reproductive disorders such as female infer-
tility, polycystic ovary syndrome, and even cancer [5,6]. Disruption
of bone morphogenetic protein 15, a member of the TGF-b super-
family, leads to defective granulosa cell (GC) differentiation and
poor oocyte development [7]. Smad proteins are the intracellular
effectors of TGF-b signaling; with the exception of Smad3 and
Smad9, knockout of the genes encoding the other receptor-associ-
ated Smads (R-Smads) or the common mediator Smad4 is embry-
onic lethal in mice [8]. In addition, selective knockout of the genes
encoding R-Smads and Smad4 in mouse ovarian follicles results in
ovulation defects and subfertility [9,10]. Conditional deletion of
Smad1 and Smad5 in ovarian GCs causes metastatic GC tumors in
female mice and phenocopies human juvenile GC tumors [11].Smad6 and Smad7 are inhibitory Smads (I-Smads) that nega-
tively regulate TGF-b signaling [12,13]. Mice homozygous for a
Smad7 hypomorphic allele have reduced body weight and litter
sizes [13], and Smad6 null mice die postnatally due to cardiac
defects [14]. As an I-Smad, Smad7 attenuates Smad2/3 signaling,
leading to the inhibition of R-Smad phosphorylation, which hin-
ders the subsequent formation of an activated R-Samds complex.
A recent study showed that Smad6 is located mainly in the oocyte,
while Smad7 is expressed in both oocytes and GCs from preantral
and antral follicles [15,16]. As mentioned above, Smad7 antago-
nizes TGF-b superfamily signaling, which is involved in the regula-
tion of oocyte-somatic cell interaction and GC function during
follicular development [16]. Overexpression of Smad7 results in
GC apoptosis, whereas siRNA-mediated knockdown of Smad7
blocks TGF-b-induced apoptosis of primary mouse GCs [15]. Over-
all, this evidence suggests that Smad7 is involved in the regulation
of GC apoptosis and ovarian follicle atresia in mammals. Previous
studies showed that Smad7 can be epigenetically silenced via his-
tone modiﬁcations and microRNAs (miRNAs) [17–19]; however,
there have been no reports of the involvement of miRNAs in the
regulation of Smad7 in the mammalian ovary. The aim of this study
was to investigate the potential regulatory roles of miR-92a in
Smad7 expression and porcine ovarian GC apoptosis.
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2.1. Isolation of porcine follicles and miRNA microarrays
Isolation of porcine follicles and miRNA microarrays were per-
formed as described in our previous report [20]. Brieﬂy, follicles
(3–5 mm in diameter) were isolated from porcine ovaries and
divided into three groups, as follows: healthy follicles (HFs), early
atretic follicles (EAFs), and progressively atretic follicles (PAFs).
Total RNAs were isolated from each group using the miRNeasy
Mini Kit. The miRNA proﬁles of each group were evaluated using
lParaﬂo miRNA microarrays (LC Sciences, Houston, TX, USA).
Quantitative reverse transcription PCR (qRT-PCR) analyses of the
expression level of miR-92a were performed using PrimeScript™
miRNA qPCR Starter Kits (TakaRa, Dalian, China). The expression
level of U6 was used as an internal control. The sequences of the
primers used are shown in Table 1. All animals work was approved
by the Animal Ethics Committee at Nanjing Agricultural University,
China.
2.2. Cell culture and transfection
GCs were collected from porcine ovarian follicles, seeded into
T25 ﬂasks, and cultured in Dulbecco’s Modiﬁed Eagle Medium/
Nutrient Mixture F-12 (DMEM/F-12; Gibco, USA) containing 15%
fetal bovine serum (FBS; Gibco, USA), 100 units/ml penicillin, and
100 mg/ml streptomycin. The GCs were incubated at 37 C for
3 days in 5% CO2/95% air. HeLa 229 cells were incubated under
the same conditions in DMEM containing 10% FBS. The miR-92a
and negative control (NC) mimics, miR-92a and inhibitor NC and
Smad7-speciﬁc and siRNA NC were purchased from GenePharma
(Shanghai, China) (Table 1). These small oligonucleotides were
transfected into cultured cells using Lipofectamine 2000 reagent
(Invitrogen, Shanghai, China), according to the manufacturer’s
instructions.
2.3. Propidium iodide and FITC-conjugated annexin V staining
The annexin V FITC/propidium iodide apoptosis kit (KeyGEN,
Nanjing, China) was used to identify cell apoptosis. Brieﬂy, cells
were washed twice with cold phosphate-buffered saline, sus-
pended in 500 ml of binding buffer containing propidium iodide
and FITC-conjugated annexin V, and then sorted by ﬂuorescence-
activated cell sorting using a Beckman Coulter (Indianapolis, IN)
instrument.
2.4. Quantitative RT-PCR
Total RNAs were isolated from the GCs using TRIzol reagent
(Invitrogen), and then reverse transcribed to cDNA using M-MLV
reverse transcriptase and oligo(dT)18 primers. Quantitative RT-PCRTable 1
Small fragments of RNA synthesized in the present study.
Name Sequences
Smad7 siRNA 50-GAC UAU GAG AAA GCG UAC ATT-30
50-UGU ACG CUU UCU CAU AGU CTT-30
NC siRNA 50-UUC UCC GAA CGU GUC ACG UTT-30
50-ACG UGA CAC GUU CGG AGA ATT-30
MiR-92a mimics 50-UAU UGC ACU UGU CCC GGC CUG U-30
50-AGG CCG GGA CAA GUG CAA UAU U-30
Mimics NC 50-UUC UCC GAA CGU GUC ACG UTT-30
50-ACG UGA CAC GUU CGG AGA ATT-30
MiR-92a inhibitor 50-ACA GGC CGG GAC AAG UGC AAU A-30
Inhibitor NC 50-CAG UAC UUU UGU GUA GUA CAA-30was performed using SYBR Premix Ex Taq in a ﬁnal reaction vol-
ume of 20 ll. The relative expression levels between samples were
calculated using the 2DDCt method with normalization to the
expression level of GAPDH as an endogenous control. The assays
were performed in triplicate and data are expressed as the
mean ± standard error. The sequences of the primers used are
listed in Table 2.
2.5. Bioinformatics analyses of miR-92a
Gene ontology and pathway analyses were performed using the
web tools MAS 3.0 (http://bioinfo.capitalbio.com/mas3). Prediction
ofmiR-92a targetswas performedusing the TargetScan v5.1 (http://
www.targetscan.org/) and miRanda (http://www.mirbase.org/)
software packages.
2.6. Plasmid construction and dual-luciferase assay
Fragments of the 30 untranslated regions (30-UTRs) of Smad6,
Smad7 and TGF-b2 containing the predicted miR-92a binding sites
were cloned and inserted between the SacI and XbaI restriction
sites in the pmirGLO Dual-Luciferase miRNA Target Expression
Vector using the primers listed in Table 2. A pmirGLO Dual-Lucifer-
ase vector containing the Smad7 30-UTR with point mutations in
the putative miR-92a seed sequences was synthesized by Generay
Biotech (Shanghai, China); the corresponding sequences were
mutated from ‘GUGCAAU’ to ‘UGAAGGG’. Prior to transfection,
GCs were plated into 6-well plates. The activities of ﬁreﬂy and
Renilla luciferase in the cell lysates were determined 24 h after
transfection using a dual-luciferase assay system (Promega, Madi-
son, WI, USA). Data were calculated as the ratio of Renilla to ﬁreﬂy
luciferase activity.
2.7. Western blotting
To determine the expression level of Smad7 protein, GCs were
collected 48 h after transfection and whole cell lysates were pre-
pared in RIPA buffer (50 mM Tris HCl, pH 8, 150 mM NaCl, 1% Non-
idet P-40, 0.1% SDS, 1% Triton X-100, and proteinase inhibitors;
Sigma). The total protein concentration was quantiﬁed using the
Bradford method and 15 lg of protein per sample was separated
by 4% or 12% SDS–PAGE (Invitrogen, Shanghai, China) and trans-
ferred to a nitrocellulose membrane. The membrane was blocked
for 2 h at room temperature in 20 mM Tris HCl containing 2%
bovine serum albumin, 150 mM NaCl, and 0.05% Tween 20. The
membrane was then incubated overnight with an anti-Smad7 rab-
bit polyclonal antibody (1:1000; Santa Cruz Biotechnology, Santa
Cruz, CA, USA), or an anti-a-tublin antibody (Sigma) as an internal
control. The membrane was incubated for a further 2 h at room
temperature with goat anti-rabbit or anti-mouse IgG-HRP
(1:2000; Cell Signaling Technology, Danvers, MA, USA). Speciﬁc
complexes were visualized using SuperSignal West Pico chemilu-
minescent substrate. The western blot analyses were performed
three times in independent experiments and Image J software
was used to analyze the signal intensities.
2.8. RNA interference
Porcine GCs were seeded into 6-well plates and transfected
with Smad7-speciﬁc siRNA and siRNA NC 24 h later, as described
in Section 2.2. The expression levels of mRNAs and proteins were
measured 24 h after transfection via qRT-PCR and western blot
analyses. Cell apoptosis was assessed at 48 h post-transfection, as
described in Section 2.3. To investigate the effect of knockdown
of Smad7 on miR-92a inhibitor-induced changes in GC apoptosis,
porcine GCs were co-transfected with a miR-92a inhibitor and
Table 2
The primers used in this study.
Gene Accession No. Primer sequence (50–30) Size (bp) Tm (C) Usage
Smad7 NM_001244175 F:CGAGCTCCAACTCATACACTCGGATGATAC 400 56 Vector construction
R:TGCTCTAGACCAGGTGATAACACCCATAG
Smad6 XM_003480446 F:CGAGCTCCAACAGCGTCCGCATCAG 408 56 Vector construction
R:TGCTCTAGAAACCCAGGCTTTTCCACCT
TGF-b2 XM_005653762 F:CGAGCTCCCTTGCTTCATCCGTGTT 477 58 Vector construction
R:TGCTCTAGACTGGCAAAGTATTTGGTCTC
Samd7 NM_001244175 F:TCACGCGGGAAGTGGAT 162 59 qRT-PCR
R:GGCTGTACGCTTTCTCATAGTC
GAPDH AF017079 F:GGACTCATGACCACGGTCCAT 220 58.0 qRT-PCR
R:TCAGATCCACAACCGACACGT
Bax AJ606301 F:CCGAAATGTTTGCTGACG 154 59.5 qRT-PCR
R:AGCCGATCTCGAAGGAAGT
Bcl-2 AB271960 F:TTCTTTGAGTTCGGTGGGG 195 62 qRT-PCR
R:CCAGGAGAAATCAAATAGAGGC
U6 F:GCTTCGGCAGCACATATACT 60 MiRNA qRT-PCR
MiR-92a F:TATTGCACTTGTCCCGGCC 58 MiRNA qRT-PCR
Fig. 1. miR-92a inhibits the granulosa cell apoptosis in porcine ovary. (A) miR-26b signals were detected in healthy follicles (HF), early atretic follicles (EAF), and
progressively atretic follicles (PAF) by miRNAmicroarray assay. (B) The relative expression levels of miR-92a were examined in HF, EAF and PAF by qRT-PCR. U6 was used as a
reference. (C) Apoptosis rate of GC when transfecting with miR-92a mimics or mimics NC. qRT-PCR analysis the expression of Bcl-2 (D) and Bax (E) when transfected with
miR-92a or mimics NC. GAPDH was used as a reference. (F) Porcine ovarian GC apoptosis level after miR-92a inhibitor treatment detected by FACS. The apoptosis rate
signiﬁcantly increased. Data were represented as the mean ± S.E.M of n = 3 experiments. ⁄P < 0.05, ⁄⁄P < 0.01.
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ing 15% FBS, and then the cells were harvested for apoptosis anal-
ysis 48 h later.
3. Results
3.1. MiR-92a inhibits porcine GC apoptosis
Microarrays were used to analyze the expression levels of
miRNAs in follicles that were isolated from porcine ovaries and
divided into HF, EAF, and progressively PAF groups. A total of 23differentially expressed miRNAs that may be associated with the
initiation of follicular atresia were identiﬁed based on the follow-
ing criteria: at least one signal value >1000 and an EAF/HF ratio
>2 or <0.7. Of these miRNAs, 12 were up-regulated and 11 were
down-regulated in the EAF group compared with the HF group
(detailed in Ref. [20]). The expression level of miR-92a, a key factor
in the apoptosis pathway [21], was markedly lower in the EAF and
PAF groups than the HF group (Fig. 1A), suggesting that this miRNA
may be relevant to the development and progression of follicular
atresia. The differential expression of miR-92a in the HF, EAF and
PAF groups was also conﬁrmed by qRT-PCR analyses (Fig. 1B).
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examine the possible role of miR-92a in GC apoptosis in the por-
cine ovary, the isolated GCs were cultured in vitro, transfected with
a miR-92a mimics or mimics NC, and then analyzed by staining
with propidium iodide and FITC-conjugated annexin V. Transfec-
tion of the GCs with the miR-92a mimics reduced the level of apop-
tosis signiﬁcantly (Fig. 1C), conﬁrming that this miRNA contributes
to the regulation of GC apoptosis in vitro. To further examine
potential mediators of miR-92a-induced GC apoptosis, qRT-PCR
was used to measure the levels of the mRNAs encoding anti-apop-
totic Bcl-2 and pro-apoptotic Bcl-2-associated X protein (Bax). Bcl-
2 mRNA expression was higher in the cells transfected with the
miR-92a mimics than those transfected with the mimics NC
(Fig. 1D); however, there was no obvious difference in the expres-
sion level of Bax between the two groups (Fig. 1E). To conﬁrm the
inhibitory effect of miR-92a on GC apoptosis, porcine GCs were
transfected with a miR-92a-speciﬁc inhibitor or inhibitor NC. As
shown in Fig. 1F, the apoptosis rate of the miR-92a inhibitor group
was signiﬁcantly higher than that of the inhibitor NC group. Taken
together, these results suggest that miR-92a inhibits GC apoptosis
in the pig ovary.
3.2. The Smad7 gene is a target of miR-92a
To understand the mechanism of miR-92a-mediated GC apop-
tosis in the porcine ovary, we searched for potential target genes
of miR-92a using the TargetScan and miRanda algorithms. Pathway
and gene ontology analyses revealed that the predicted targets
were mainly involved in cell proliferation, survival, and apoptosis.Fig. 2. Luciferase activities of TGF-b2, Smad6 and Smad7. (A) There was a signiﬁcant dow
TGF-b2 (B–C). (D) The putative miR-92a-binding sites in the porcine Smad7 30-UTR was lab
luciferase activity assay of Hela 229 cells after co-transfected miR-92a mimics or mimics
primGLO-30-UTR vector. Smad7-mt: mutation of Smad7 primGLO-30-UTR vector in miR-
⁄P < 0.05.The list of targets included TGF-b2, Smad6 and Smad7, all of which
play critical roles in folliculogenesis, GC proliferation, and apopto-
sis in mammalian ovaries [16,23,24]; hence, these genes were
selected for further analysis. Dual-luciferase vectors (pmirGLO)
containing the 30-UTR of porcine TGF-b2, Smad6 or Smad7 were
constructed and co-transfected into HeLa 229 cells along with a
miR-92a mimics or mimics NC. Expression of the miR-92a mimics
down-regulated the luciferase activity in the cells expressing the
Smad7 vector (Fig. 2A) but did not affect that in the cells expressing
the Smad6 (Fig. 2B) or TGF-b2 (Fig. 2C) vector, suggesting that the
porcine Smad7 gene is a target of miR-92a.
To determine whether miR-92a binds to, and regulates, Smad7
directly, a dual-luciferase vector containing the 30-UTR of Smad7
in which the putative miR-92a-binding sequences were mutated
(Fig. 2D) was co-transfected into HeLa 229 cells along with a
miR-92a mimics or mimics NC. In this experiment, overexpression
of the miR-92a mimics had no effect on the luciferase activity
(Fig. 2E), conﬁrming that miR-92a suppresses pig Smad7 by bind-
ing directly to the 30-UTR of the Smad7 gene.
3.3. MiR-92a inhibits apoptosis by targeting the Smad7 gene in GCs
Smad7 is a TGF-b-inducible mediator of apoptosis in GCs [15].
To examine the regulation of Smad7 expression by miR-92a,
in vitro cultured porcine GCs were transfected with a miR-92a
mimics or mimics NC or inhibitor. As shown in Fig. 3A, the level
of Smad7 mRNA was decreased or increased signiﬁcantly after
transfection of the GCs with the miR-92a mimics or inhibitor,
respectively. Similarly, western blot analyses revealed that overex-n-regulation of Smad7 luciferase activity, but there were no changes for Smad6 and
eled by red letters and the blue letters indicate the region that was mutated. (E) The
NC with Smad7-mt primGLO-30-UTR reporter vector. Smad7-wt: wild type of Smad7
92a binding sits. Data were represented as the mean ± S.E.M of n = 3 experiments.
Fig. 3. Smad7 expression was reduced in granulosa cell transfected with miR-92a mimics. The expression of Smad7 mRNA (A) and protein (B) after miR-92a mimics or miR-
92a inhibitor transfection in GCs. Data were represented as the mean ± S.E.M of n = 3 experiments. ⁄P < 0.05, ⁄⁄P < 0.01.
Fig. 4. Smad7 promotes apoptosis and rescues the effects of miR-92a in granulosa cells. (A) Smad7-siRNA treatment decreases the mRNA expression of Smad7. (B) Smad7-
siRNA inhibits protein expression of Smad7. (C)Knockdown of endogenous Smad7 effects Bcl-2mRNA. (D) Knockdown of endogenous Smad7 effect BaxmRNA. (E) Knockdown
of endogenous Smad7 effects GC apoptosis. (F) Smad7 rescue the effects of miR-92a in GCs. GC apoptosis rate was detected by FASC 48 h after co-transfected Smad7-siRNA
with miR-92a inhibitor into GCs. Data were represented as the mean ± S.E.M of n = 3 experiments. ⁄P < 0.05, ⁄⁄P < 0.01.
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level of Smad7 protein, respectively (Fig. 3B). In summary, these
results indicate that Smad7 is a functional target of miR-92a in
pig ovarian GCs.3.4. Smad7 promotes apoptosis in GCs
To assess the relevance of miR-92a-induced down-regulation of
Smad7 to ovarian GC apoptosis in pigs, Smad7 was knocked down
4502 J. Liu et al. / FEBS Letters 588 (2014) 4497–4503by RNA interference. As shown in Fig. 4A and B, transfection of por-
cine GCs with a Smad7-speciﬁc siRNA inhibited the expression lev-
els of the Smad7 mRNA and protein effectively. In addition,
knockdown of Smad7 reduced the apoptosis rate of the GCs
(Fig. 4C) and the expression level of Bcl-2 (Fig. 4D), while increased
the expression level of Bax (Fig. 4E). Furthermore, apoptosis
induced by transfection of porcine GCs with a miR-92a inhibitor
was inhibited when Smad7 expression was knocked down
(Fig. 4F). These results conﬁrm that Smad7 is a direct functional
target of miR-92a in porcine ovarian GCs.
4. Discussion
In mammalian ovaries, more than 99% of the follicles undergo
degenerative atresia, and only a few follicles ovulate during ovar-
ian follicular development. GCs play a key role in follicular devel-
opment and atresia, and the apoptosis of GCs is closely related to
follicular atresia [22]. In 2007, Murchison et al. [25] and Lei et al.
[26] demonstrated that miRNAs play an important role in ovarian
function and GC apoptosis by speciﬁc knockout of the enzyme
Dicer, which plays a central role in the biogenesis of miRNAs. Since
then, more and more attention has been focused on the role of
miRNAs in the regulation of GC apoptosis; for example, in 2010,
Carletti et al. [27] showed that miR-21 can inhibit GC apoptosis
in mice, thereby demonstrating a potential key role of miRNAs in
this process in mammals. In livestock ovarian tissue, miRNAs are
involved not only in the regulation of follicular luteinizing [28],
but also the regulation of follicular GC apoptosis [20]. Here, miR-
92a was identiﬁed as a key regulator of GC apoptosis in mammals.
The expression level of miR-92a was down-regulated during por-
cine ovarian follicular atresia and overexpression of this miRNA
inhibited apoptosis of in vitro cultured follicular GCs. Similarly,
recent studies have shown that miR-92a, a member of the miR-
17–92 cluster, inhibits apoptosis and promotes the proliferation
of other cell types, including glioma [29], lymphoma [30] and
endothelial [21] cells. Together with the results presented here,
these ﬁndings suggest that miR-92a is an anti-apoptotic factor that
inhibits GC apoptosis in pig ovaries.
MiRNAs are small (approximately 20–23 nucleotide), double-
stranded, non-coding RNAs that play critical roles in the regulation
of gene expression by binding to, and promoting, the translational
repression or degradation of target mRNAs [31]. Here, the Smad7
gene, which encodes an I-Smad belonging to the TGF-b superfamily,
was identiﬁed as a miR-92a target via bioinformatics analyses and
dual-luciferase reporter assays. Like Smad6, Smad7 can also block
the TGF-b and bone morphogenetic protein signaling pathway,
albeit via a different regulatory mechanism [32]. Smad7 down-reg-
ulates TGF-b signaling through a negative feedback loop [33], can
induce apoptosis of human prostatic carcinoma cells [34], and plays
an important role in TGF-b-induced apoptosis by interacting with
b-catenin [35]. Smad7 expression can also potentiate apoptosis
through caspase-3-independent and TGF-b-independent mecha-
nisms [36]. In addition, recent studies demonstrated that Smad7
promotes GC apoptosis in themouse ovary [15]. Here,we found that
miR-92a regulates Smad7 expression in pig ovarian GCs at both the
mRNA and protein level. In addition, knockdown of Smad7 pre-
vented the pro-apoptotic effect of miR-92a inhibition in porcine
ovarian GCs. Therefore, we speculate that miR-92a inhibits GC
apoptosis by targeting the Smad7 gene.
In conclusion, we found that miR-92a is expressed at a high level
in HFs and can inhibit GC apoptosis in pig ovaries signiﬁcantly.
Smad7, a major inhibitory regulator of the TGF-b/SMAD signaling
pathway, was conﬁrmed as a functional target of miR-92a. The
results presented here provide a new insight into the mechanism
of ovarian follicular atresia in pigs. Further investigations will focuson the effects ofmiR-92a on the TGF-b pathway in vivo. Inhibition of
GC apoptosis and follicular atresia by miR-92a will contribute to
both ovulation and litter sizes of pigs; hence, manipulation of this
miRNA may have wide applications in livestock husbandry.
Acknowledgements
This work was supported by a Grant from the Fundamental
Research Funds for the Central Universities (No. KYZ201152), the
National Key Scientiﬁc Program Grant (2014CB138502) and the
National Natural Science Foundation of China (No. 30901027).
References
[1] Heldin, C.H., Landstrom, M. and Moustakas, A. (2009) Mechanism of TGF-beta
signaling to growth arrest, apoptosis, and epithelial–mesenchymal transition.
Curr. Opin. Cell Biol. 21, 166–176.
[2] Massague, J. (2012) TGFbeta signalling in context. Nat. Rev. Mol. Cell Biol. 13,
616–630.
[3] Chang, H., Brown, C.W. and Matzuk, M.M. (2002) Genetic analysis of the
mammalian transforming growth factor-beta superfamily. Endocr. Rev. 23,
787–823.
[4] Kuo, S.W., Ke, F.C., Chang, G.D., Lee, M.T. and Hwang, J.J. (2011) Potential role of
follicle-stimulating hormone (FSH) and transforming growth factor
(TGFbeta1) in the regulation of ovarian angiogenesis. J. Cell. Physiol. 226,
1608–1619.
[5] Pangas, S.A., Li, X., Umans, L., Zwijsen, A., Huylebroeck, D., Gutierrez, C., Wang,
D., Martin, J.F., Jamin, S.P., Behringer, R.R., Robertson, E.J. and Matzuk, M.M.
(2008) Conditional deletion of Smad1 and Smad5 in somatic cells of male and
female gonads leads to metastatic tumor development in mice. Mol. Cell. Biol.
28, 248–257.
[6] Laissue, P., Christin-Maitre, S., Touraine, P., Kuttenn, F., Ritvos, O., Aittomaki, K.,
Bourcigaux, N., Jacquesson, L., Bouchard, P., Frydman, R., Dewailly, D., Reyss,
A.C., Jeffery, L., Bachelot, A., Massin, N., Fellous, M. and Veitia, R.A. (2006)
Mutations and sequence variants in GDF9 and BMP15 in patients with
premature ovarian failure. Eur. J. Endocrinol. 154, 739–744.
[7] Su, Y.Q., Wu, X., O’Brien, M.J., Pendola, F.L., Denegre, J.N., Matzuk, M.M. and
Eppig, J.J. (2004) Synergistic roles of BMP15 and GDF9 in the development and
function of the oocyte-cumulus cell complex in mice: genetic evidence for an
oocyte-granulosa cell regulatory loop. Dev. Biol. 276, 64–73.
[8] Pangas, S.A. (2012) Bone morphogenetic protein signaling transcription factor
(SMAD) function in granulosa cells. Mol. Cell. Endocrinol. 356, 40–47.
[9] Pangas, S.A. (2012) Regulation of the ovarian reserve by members of the
transforming growth factor beta family. Mol. Reprod. Dev. 79, 666–679.
[10] Yu, C., Zhang, Y.L. and Fan, H.Y. (2013) Selective Smad4 knockout in ovarian
preovulatory follicles results in multiple defects in ovulation. Mol. Endocrinol.
27, 966–978.
[11] Tripurani, S.K., Cook, R.W., Eldin, K.W. and Pangas, S.A. (2013) BMP-speciﬁc
SMADs function as novel repressors of PDGFA and modulate its expression in
ovarian granulosa cells and tumors. Oncogene 32, 3877–3885.
[12] Nakao, A., Okumura, K. and Ogawa, H. (2002) Smad7: a new key player in TGF-
beta-associated disease. Trends Mol. Med. 8, 361–363.
[13] Li, R., Rosendahl, A., Brodin, G., Cheng, A.M., Ahgren, A., Sundquist, C., Kulkarni,
S., Pawson, T., Heldin, C.H. and Heuchel, R.L. (2006) Deletion of exon I of
SMAD7 in mice results in altered B cell responses. J. Immunol. 176, 6777–
6784.
[14] Galvin, K.M., Donovan, M.J., Lynch, C.A., Meyer, R.I., Paul, R.J., Lorenz, J.N.,
Fairchild-Huntress, V., Dixon, K.L., Dunmore, J.H., Gimbrone Jr., M.A., Falb, D.
and Huszar, D. (2000) A role for smad6 in development and homeostasis of the
cardiovascular system. Nat. Genet. 24, 171–174.
[15] Quezada, M., Wang, J., Hoang, V. and McGee, E.A. (2012) Smad7 is a
transforming growth factor-beta-inducible mediator of apoptosis in
granulosa cells. Fertil. Steril. 97 (1452–1459), 1451–1456.
[16] Gao, Y., Wen, H., Wang, C. and Li, Q. (2013) SMAD7 antagonizes key TGFbeta
superfamily signaling in mouse granulosa cells in vitro. Reproduction 146, 1–
11.
[17] Liu, X., Nagarajan, R.P., Vale, W. and Chen, Y. (2002) Phosphorylation
regulation of the interaction between Smad7 and activin type I receptor.
FEBS Lett. 519, 93–98.
[18] Simonsson, M., Heldin, C.H., Ericsson, J. and Gronroos, E. (2005) The balance
between acetylation and deacetylation controls Smad7 stability. J. Biol. Chem.
280, 21797–21803.
[19] Chang, Y., Liu, C., Yang, J., Liu, G., Feng, F., Tang, J., Hu, L., Li, L., Jiang, F., Chen, C.,
Wang, R., Yang, Y., Jiang, X., Wu, M., Chen, L. and Wang, H. (2013) MiR-20a
triggers metastasis of gallbladder carcinoma. J. Hepatol. 59, 518–527.
[20] Lin, F., Li, R., Pan, Z.X., Zhou, B., Yu de, B., Wang, X.G., Ma, X.S., Han, J., Shen, M.
and Liu, H.L. (2012) MiR-26b promotes granulosa cell apoptosis by targeting
ATM during follicular atresia in porcine ovary. PLoS One 7, e38640.
[21] Zhang, L., Zhou, M., Qin, G., Weintraub, N.L. and Tang, Y. (2014) MiR-92a
regulates viability and angiogenesis of endothelial cells under oxidative stress.
Biochem. Biophys. Res. Commun..
J. Liu et al. / FEBS Letters 588 (2014) 4497–4503 4503[22] Matsuda, F., Inoue, N., Manabe, N. and Ohkura, S. (2012) Follicular growth and
atresia in mammalian ovaries: regulation by survival and death of granulosa
cells. J. Reprod. Dev. 58, 44–50.
[23] Gueripel, X., Benahmed, M. and Gougeon, A. (2004) Sequential gonadotropin
treatment of immature mice leads to ampliﬁcation of transforming growth
factor beta action, via upregulation of receptor-type 1, Smad 2 and 4, and
downregulation of Smad 6. Biol. Reprod. 70, 640–648.
[24] Fenwick, M.A., Mora, J.M., Mansour, Y.T., Baithun, C., Franks, S. and Hardy, K.
(2013) Investigations of TGF-beta signaling in preantral follicles of female
mice reveal differential roles for bone morphogenetic protein 15.
Endocrinology 154, 3423–3436.
[25] Murchison, E.P., Stein, P., Xuan, Z., Pan, H., Zhang, M.Q., Schultz, R.M. and
Hannon, G.J. (2007) Critical roles for Dicer in the female germline. Genes Dev.
21, 682–693.
[26] Lei, L., Jin, S., Gonzalez, G., Behringer, R.R. and Woodruff, T.K. (2010) The
regulatory role of Dicer in folliculogenesis in mice. Mol. Cell. Endocrinol. 315,
63–73.
[27] Carletti, M.Z., Fiedler, S.D. and Christenson, L.K. (2010) MicroRNA 21 blocks
apoptosis in mouse periovulatory granulosa cells. Biol. Reprod. 83, 286–
295.
[28] McBride, D., Carre, W., Sontakke, S.D., Hogg, C.O., Law, A., Donadeu, F.X. and
Clinton, M. (2012) Identiﬁcation of miRNAs associated with the follicular-
luteal transition in the ruminant ovary. Reproduction 144, 221–233.
[29] Niu, H., Wang, K., Zhang, A., Yang, S., Song, Z., Wang, W., Qian, C., Li, X., Zhu, Y.
and Wang, Y. (2012) MiR-92a is a critical regulator of the apoptosis pathwayin glioblastoma with inverse expression of BCL2L11. Oncol. Rep. 28, 1771–
1777.
[30] Lv, X.B., Zhang, X., Deng, L., Jiang, L., Meng, W., Lu, Z. and Wang, X. (2014) MiR-
92a mediates AZD6244 induced apoptosis and G1-phase arrest of lymphoma
cells by targeting Bim. Cell Biol. Int. 38, 435–443.
[31] Bonauer, A., Carmona, G., Iwasaki, M., Mione, M., Koyanagi, M., Fischer, A.,
Burchﬁeld, J., Fox, H., Doebele, C., Ohtani, K., Chavakis, E., Potente, M., Tjwa, M.,
Urbich, C., Zeiher, A.M. and Dimmeler, S. (2009) MicroRNA-92a controls
angiogenesis and functional recovery of ischemic tissues in mice. Science 324,
1710–1713.
[32] Goto, K., Kamiya, Y., Imamura, T., Miyazono, K. and Miyazawa, K. (2007)
Selective inhibitory effects of Smad6 on bone morphogenetic protein type I
receptors. J. Biol. Chem. 282, 20603–20611.
[33] Nicklas, D. and Saiz, L. (2013) Characterization of negative feedback network
motifs in the TGF-beta signaling pathway. PLoS ONE 8, e83531.
[34] Landstrom, M., Heldin, N.E., Bu, S., Hermansson, A., Itoh, S., ten Dijke, P. and
Heldin, C.H. (2000) Smad7 mediates apoptosis induced by transforming
growth factor beta in prostatic carcinoma cells. Curr. Biol. 10, 535–538.
[35] Edlund, S., Lee, S.Y., Grimsby, S., Zhang, S., Aspenstrom, P., Heldin, C.H. and
Landstrom, M. (2005) Interaction between Smad7 and beta-catenin:
importance for transforming growth factor beta-induced apoptosis. Mol.
Cell. Biol. 25, 1475–1488.
[36] Davoodpour, P. and Landstrom, M. (2005) 2-Methoxyestradiol-induced
apoptosis in prostate cancer cells requires Smad7. J. Biol. Chem. 280,
14773–14779.
